Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Single Arm, Single-center, Phase 1 Trial Investigating the Effect of 7-days-repeated Administration of Linaprazan Glurate on the Pharmacokinetics of Repeated Doses of Amoxicillin in Healthy Participants

NCT07308041 is registered in ClinicalTrials.gov with Cinclus Pharma Holding AB as lead sponsor.

NCT NCT07308041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Single Arm, Single-center, Phase 1 Trial Investigating the Effect of 7-days-repeated Administration of Linaprazan Glurate on the Pharmacokinetics of Repeated Doses of Amoxicillin in Healthy Participants
Lead sponsor
Cinclus Pharma Holding AB
Phase
Phase 1
Overall status
Completed
Start date
November 11, 2025
Completion date
December 22, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug interaction, gerd (gastroesophageal reflux disease), safety, and tolerability